Search Results
22 items found for "Biomarker"
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
and Immunology Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers approach Published date November 27, 2023 Abstract "Somatostatin receptors are clinically validated GPCR biomarkers We suggest that SST2 and SST3 should be further explored as potential biomarkers and therapeutic tools
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
Hence, identifying the crucial pathways and biomarkers for the treatment of GBM is of prime importance Our findings suggest that the GNAI3 gene holds potential as a prognostic biomarker for GBM. Chih-Yang Wang Tags G-protein-coupled receptor (GPCR) , genome , glioblastoma , malignancy , molecular biomarker
- The path of GPR87: from a P2Y-like receptor to its role in cancer progression
Furthermore, the importance of the expression of GPR87 as a predictive biomarker for evaluating the prognosis Sak Tags Carcinogenesis , GPR87 , LPA receptor , Metastasis , Orphan GPCR , P2Y receptor , Prognostic biomarker
- SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma
Additionally, SSTR2 has potential as a new biomarker for poor prognosis in NPC patients." Authors Yue Xu, Zihan Quan, Yuting Zhan, Haihua Wang, Jiadi Luo, Weiyuan Wang, Songqing Fan Tags biomarkers
- Abstract Submission Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Aging Basic and Clinical Pharmacology Proteomic and Transcriptomics Biosensors and Molecular Tools Biomarkers
- miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population
< GPCR News < GPCRs in Oncology and Immunology miR-19a may function as a biomarker of oral squamous cell
- Ep 90 with Dr. Nariman Balenga
A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and
- Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers
recent clinical progress of CXCR2 small molecule antagonists, we speculated that CXCR2 can be used as a biomarker
- Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling
Colorectal cancer (CRC) remains a major global cause of cancer-related mortality, lacking effective biomarkers
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
In fact, KLK3 is the specific prostate antigen, the only tissue-specific biomarker used to diagnose this
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
Additionally, receiver operator characteristic curve analysis suggested these genes' potential as biomarkers
- Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
16, 2023 Abstract "Background: In this study, we aimed to investigate the potential of miR-19a as a biomarker
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
kinases (SFK) within PANC-1 cells, as shown by FAK phosphorylation at Tyr576/577 and Tyr861, sensitive biomarkers
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Ridinger , Pamela S Becker , Tara L Lin , Sandra L Silberman , Eunice S Wang , Amer M Zeidan Tags AML , Biomarker
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target
In the Cox proportional hazards model, β2-AR was identified as a prognostic biomarker of OSCC (p = 0.047
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
PAXIP1-AS1 could be a promising prognosis biomarker and response to immunotherapy for OC."
- Classified News | Dr. GPCR Ecosystem
November 26, 2024 Integrated bioinformatics analysis reveals that CCBP2 and GPR87 are new GPCR-associated biomarkers
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Sabbagh was recruited by Vertex Pharmaceuticals (Canada) where he worked on biomarker discovery for inflammatory
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
identifying which will progress to invasive disease remains difficult highlighting an urgent need for new biomarkers Recent studies identify CELSR1, a key PCP gene, as a novel biomarker for early-stage breast cancer.
- Ep 146 with Dr Michael Feigin
culture of normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
joining UAB as a graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers
- Ep 38 with Dr. Alexander S. Hauser
cluster in Copenhagen and at the Institute of Biological Psychiatry in Roskilde working with the UK Biobank